A mouse model of the most aggressive subgroup of human medulloblastoma.

Cancer Cell
Daisuke KawauchiMartine F Roussel

Abstract

Medulloblastomas that display a large cell/anaplastic morphology and overexpress the cellular c-MYC gene are highly aggressive and carry a very poor prognosis. This so-called MYC-subgroup differs in its histopathology, gene expression profile, and clinical behavior from other forms of medulloblastoma. We generated a mouse model of MYC-subgroup medulloblastoma by transducing Trp53-null cerebellar progenitor cells with Myc. The cardinal features of these mouse medulloblastomas closely mimic those of human MYC-subgroup tumors and significantly differ from mouse models of the Sonic-Hedgehog- and WNT-disease subgroups. This mouse model should significantly accelerate understanding and treatment of the most aggressive form of medulloblastoma and infers distinct roles for MYC and MYCN in tumorigenesis.

References

Sep 30, 1994·Science·H Hermeking, D Eick
May 1, 1997·Trends in Biochemical Sciences·C Grandori, R N Eisenman
Oct 29, 1999·Genes & Development·C M EischenJ L Cleveland
Oct 14, 2000·Annual Review of Cell and Developmental Biology·C GrandoriR N Eisenman
Nov 2, 2001·Nature·T ReyaI L Weissman
Aug 31, 2002·Science·David M BermanPhilip A Beachy
Jul 2, 2003·Journal of Neuropathology and Experimental Neurology·Charles S McManamyUNKNOWN United Kingdom Children's Cancer Study Group
Aug 14, 2003·Gene Expression Patterns : GEP·Ellen A LumpkinJane E Johnson
Feb 19, 2004·Brain Research. Molecular Brain Research·Adrian J FrankRichard J Gilbertson
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
May 24, 2005·Nature Neuroscience·Audra LeeRobert J Wechsler-Reya
Jun 21, 2005·Genes & Development·Sophia W M BruggemanMaarten van Lohuizen
Oct 18, 2005·Cancer Cell·Michael D TaylorRichard J Gilbertson
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W EllisonUNKNOWN United Kingdom Children's Cancer Study Group Brain Tumour Committee
Mar 29, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaret C ThompsonRichard J Gilbertson
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Frederique ZindyMartine F Roussel
Feb 26, 2008·Cell·Jose Silva, Austin Smith
Oct 29, 2008·Oncogene·B Hoffman, D A Liebermann
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan PfisterAndrey Korshunov
Aug 5, 2009·Cell Cycle·Wenjing LiChristine J Watson
Apr 28, 2010·Gastroenterology·Matilde TodaroGiorgio Stassi
May 19, 2010·Genes & Development·Fredrik J SwartlingLouis Chesler
Sep 9, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul A NorthcottMichael D Taylor
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W EllisonSteven C Clifford

❮ Previous
Next ❯

Citations

Oct 23, 2012·Cancer Metastasis Reviews·Fredrik J SwartlingWilliam A Weiss
Jun 23, 2012·Nature·Giles RobinsonRichard J Gilbertson
Jan 22, 2013·Nature Cell Biology·Cédric Blanpain
Nov 24, 2012·Nature Reviews. Cancer·Paul A NorthcottStefan M Pfister
Oct 1, 2013·Current Opinion in Oncology·Marc RemkeMichael D Taylor
May 15, 2013·Molecular and Cellular Biology·Jordi BerenguerSebastian Pons
Nov 13, 2012·The Journal of Clinical Investigation·Lori S HartConstantinos Koumenis
Dec 13, 2012·Future Oncology·Tenley C Archer, Scott L Pomeroy
May 30, 2014·Acta Neuropathologica·Julia PöschlUlrich Schüller
Apr 24, 2014·Future Oncology·Soumen Khatua, Wafik Zaky
Jul 11, 2014·Cellular and Molecular Life Sciences : CMLS·Iva Simeonova, Emmanuelle Huillard
Oct 30, 2013·Oncogene·S-M HedeF J Swartling
Oct 29, 2014·Nature Reviews. Clinical Oncology·Amar J Gajjar, Giles W Robinson
Aug 3, 2012·Expert Review of Neurotherapeutics·Paul A NorthcottMichael D Taylor
Nov 1, 2015·Journal of Neuro-oncology·Noah C JenkinsDaniel W Fults
Nov 1, 2015·Journal of Neuro-oncology·Marie MorfouaceMartine F Roussel
Jan 15, 2016·Cancer Cell·Haritha Mathsyaraja, Robert N Eisenman
Jul 17, 2012·Cancer Letters·Branavan ManoranjanSheila K Singh
Jan 15, 2016·Cancer Cell·BaoHan T VoMartine F Roussel
Dec 22, 2015·Bulletin du cancer·Laure Bihannic, Olivier Ayrault
Sep 15, 2015·Cell Reports·Franz KratochvillPeter J Murray
Feb 26, 2013·Brain Pathology·David T W JonesStefan M Pfister
Mar 22, 2016·Cell Reports·Lukas Tamayo-OrregoFrédéric Charron
Jul 18, 2014·Acta Neuropathologica Communications·Gabriel A Bien-Willner, Robi D Mitra
Apr 9, 2014·Acta Neuropathologica Communications·Giulio FiaschettiMichael A Grotzer
Sep 10, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Patryk SkowronMichael D Taylor
Sep 1, 2015·Neurobiology of Disease·Kevin Kiyoshi NoguchiNuri B Farber
Dec 21, 2012·Pediatric Blood & Cancer·Amar GajjarUNKNOWN COG Brain Tumor Committee
Jul 16, 2013·International Journal of Cancer. Journal International Du Cancer·Jeannine LacroixHendrik Witt
Apr 7, 2016·Cancer Cell·Timothy N PhoenixRichard J Gilbertson
May 30, 2015·Journal of Neurosurgery. Pediatrics·Branavan Manoranjan, Sheila K Singh
Oct 22, 2013·The Lancet Oncology·Vijay RamaswamyMichael D Taylor
Feb 5, 2013·Experimental Neurology·Fredrik J SwartlingAnders I Persson
Nov 28, 2012·Experimental Neurology·Jun Wang, Robert J Wechsler-Reya
Jul 16, 2013·Pediatric Hematology and Oncology·Kornelius KerlMichael C Frühwald
Mar 13, 2014·Molecules and Cells·Rebecca Bish, Christine Vogel
Nov 26, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M O JacusC F Stewart
Feb 22, 2012·Cancer Cell·Charles G Eberhart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.